← Back to Search

Universal Gloving for C. Difficile Infection (GLORI Trial)

N/A
Waitlist Available
Led By Nasia Safdar, MD PhD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18 years of age or older
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
No Placebo-Only Group

Summary

This trial will compare the effectiveness of universal gloving practices to the standard of care in order to determine if the former can help prevent healthcare-associated Clostridium difficile infections.

Who is the study for?
This trial is for adult patients and healthcare workers in certain VA hospital units, including acute medical or surgical wards. Units must be able to collect data and have support from hospital leadership. It's not for those in long-term care, mixed-acuity, intensive care, or specialty units.
What is being tested?
The study tests if wearing gloves all the time (universal gloving) by healthcare workers can prevent the spread of C. difficile better than just using gloves with known infected patients (standard practice).
What are the potential side effects?
While there are no direct side effects mentioned for participants, universal gloving may impact hand hygiene practices and could potentially lead to increased glove-related skin irritation among healthcare workers.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
C. difficile acquisition rates
Secondary study objectives
30-day mortality rate
CAUTI (HAI) rates
CLABSI (HAI) rates
+7 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Enact universal gloving practices
Group II: ControlActive Control1 Intervention
Continue standard of care gloving practices

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,664 Previous Clinical Trials
3,765,794 Total Patients Enrolled
University of Wisconsin, MadisonOTHER
1,230 Previous Clinical Trials
3,199,815 Total Patients Enrolled
2 Trials studying Clostridium Difficile
11,033 Patients Enrolled for Clostridium Difficile
Nasia Safdar, MD PhDPrincipal InvestigatorWilliam S. Middleton Memorial Veterans Hospital, Madison, WI
5 Previous Clinical Trials
11,242 Total Patients Enrolled
1 Trials studying Clostridium Difficile
11,000 Patients Enrolled for Clostridium Difficile

Media Library

Universal gloving Clinical Trial Eligibility Overview. Trial Name: NCT04036058 — N/A
Clostridium Difficile Research Study Groups: Control, Intervention
Clostridium Difficile Clinical Trial 2023: Universal gloving Highlights & Side Effects. Trial Name: NCT04036058 — N/A
Universal gloving 2023 Treatment Timeline for Medical Study. Trial Name: NCT04036058 — N/A
~3 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top